ITI Pharma and Healthcare Fund Regular vs Quant Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹402 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹1000 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 17 Jun 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare TRI |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.39 |
Manager | Rohan Korde | Sanjeev Sharma |
ISIN Code | INF00XX01BL5 | INF966L01CG3 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Month | 7.29% | 6.87% |
6 Month | -7.99% | -17.61% |
1 Year | 15.65% | 7.45% |
3 Year | 18.39% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
6 Month | -2.39% | -6.5% |
1 Year | 6.67% | -13.13% |
3 Year | 24.36% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Year | 22.47% | 55.41% |
3 Year | 18.57% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Standard Deviation | 15.667% | - |
Sharp | 0.739% | - |
Beta | 0.959% | - |
Alpha | -1.413% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Name | Rohan Korde | Sanjeev Sharma |
Total AUM | ₹4626 Cr | ₹39731 Cr |
Funds Managed | 10 | 22 |
ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 7.57 | 3.06 |
Mid Cap | 31.22 | 13.75 |
Small Cap | 32.03 | 52.32 |
Large Cap | 29.19 | 30.87 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 8.42 | 3.06 |
Healthcare | 88.76 | 79.02 |
Basic Materials | 2.08 | - |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Energy | - | 6.71 |
Technology | - | 5.45 |
Consumer Defensive | - | 5.77 |
Top Comparisons
Nippon India Balanced Advantage Fund-Growth Plan-Bonus Option
3Y Returns11.83%
360 ONE Balanced Hybrid Fund Regular - Growth
3Y Returns0%
ICICI Prudential Equity Arbitrage Fund - Growth
3Y Returns6.66%
Edelweiss Arbitrage Fund- Regular Plan- Growth Option
3Y Returns6.71%
ICICI Prudential Value Discovery Fund - Growth
3Y Returns20.2%
BANDHAN Sterling Value Fund - Regular Plan - Growth
3Y Returns16.74%
INVESCO INDIA FOCUSED FUND - Growth
3Y Returns19.91%
Quant Focused Fund-Growth
3Y Returns13.99%